Comparison Between Oral Anticoagulation and Left Atrial Appendage Occlusion in the Prevention of Stroke With Regard to Non-Valvular Atrial Fibrillation
| Autor: | Osama Sandhu, Safeera Khan, Shermeen Rahmat, Adarsh Thomas Anthony, Zarmeena Aftab |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
left atrial appendage occlusion medicine.medical_treatment Cardiology 030204 cardiovascular system & hematology Left atrial appendage occlusion law.invention 03 medical and health sciences 0302 clinical medicine Randomized controlled trial Oral administration law Internal medicine Internal Medicine medicine cardiovascular diseases Stroke oral anticoagulation business.industry General Engineering Warfarin Atrial fibrillation medicine.disease stroke non valvular atrial fibrillation cardiovascular system Rheumatic fever Pouch business 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | Cureus |
| ISSN: | 2168-8184 |
| DOI: | 10.7759/cureus.10437 |
| Popis: | In the past, the most common type of atrial fibrillation leading to stroke was valvular; this was predominantly due to the prevalence of rheumatic fever, but with the advent of better-hospitalized care, the cases of valvular atrial fibrillation declined. In recent years, there has been an increase in cases of stroke due to non-valvular atrial fibrillation. Stasis of blood in the left atrial pouch leads to coagulation and thrombi formation, which may lead to stroke. Oral medication or mechanical intervention can prevent thrombi formation. Both oral anticoagulation and left atrial appendage occlusion (LAAO) have been compared to see which has better outcomes. It was observed that LAAO has greater efficacy, but with time throughout a couple of years, no considerable difference was seen when compared to warfarin. Most of the long-term randomized controlled trials have been performed with the Watchman® device. Although the Lariat and Amplatzer LAAO devices have also shown favorable outcomes, there is still a deficiency when it comes to trials of high-quality evidence using these devices as an intervention. Dual therapy with both of these approaches showed a decline in the count of major bleeding episodes on follow-up. Overall, albeit both methods have proven useful, LAAO has a slight advantage in efficacy and leads to less hemorrhagic events. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|